{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:02:41Z","timestamp":1776988961473,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.ijrobp.2011.02.012","type":"journal-article","created":{"date-parts":[[2011,5,20]],"date-time":"2011-05-20T12:57:42Z","timestamp":1305896262000},"page":"e231-e235","source":"Crossref","is-referenced-by-count":6,"title":["Weekly Gemcitabine and Cisplatin in Combination With Radiotherapy in Patients With Locally Advanced Head-and-Neck Cancer: Phase I Study"],"prefix":"10.1016","volume":"81","author":[{"given":"Gustavo Arruda","family":"Viani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio Luis","family":"Afonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian Cardoso","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas Godoi","family":"Bernardes da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo Jose","family":"Stefano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2011.02.012_bib1","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-0","article-title":"Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer","volume":"355","author":"Pignon","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2011.02.012_bib2","first-page":"1624","article-title":"A phase III comparison of standard radiation therapy versus split course RT plus concurrent cisplatin versus RT plus concurrent cisplatin and 5-fluorouracil in patients with unresectable squamous cell head and neck cancer: An intergroup study","volume":"19","author":"Adelstein","year":"2000","journal-title":"Proc Am Soc Clin Oncol"},{"issue":"Suppl. 6","key":"10.1016\/j.ijrobp.2011.02.012_bib3","doi-asserted-by":"crossref","first-page":"vi7","DOI":"10.1093\/annonc\/mdi452","article-title":"Current clinical outcomes demand new treatment options for SCCHN","volume":"16","author":"Lefebvre","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2011.02.012_bib4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/ncponc0750","article-title":"The chemoradiation paradigm in head and neck cancer","volume":"4","author":"Seiwert","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"issue":"Suppl. 11","key":"10.1016\/j.ijrobp.2011.02.012_bib5","first-page":"19","article-title":"Induction of apoptosis by gemcitabine","volume":"22","author":"Huang","year":"1995","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ijrobp.2011.02.012_bib6","article-title":"Evaluation of the antitumor activity of gemcitabine (2\u2032,2\u2032-difluoro-2\u2032-deoxycytidine)","volume":"50","author":"Hertel","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2011.02.012_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0305-7372(96)90014-6","article-title":"Clinical, toxicological and pharmacological aspects of gemcitabine","volume":"22","author":"Guchelaar","year":"1996","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ijrobp.2011.02.012_bib8","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/oxfordjournals.annonc.a058910","article-title":"A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group","volume":"5","author":"Catimel","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2011.02.012_bib9","first-page":"392a","article-title":"Phase II trial of cisplatin (C) and gemcitabine (G) in advanced squamous cell carcinoma of the head and neck (AHNC) [Abstract]","volume":"17","author":"Garcia-Carbonero","year":"1998","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.ijrobp.2011.02.012_bib10","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0360-3016(95)02134-5","article-title":"Radiosensitization of pancreatic cancer cells by 2\u2032,2\u2032-difluoro-2\u2032-deoxycytidine","volume":"34","author":"Lawrence","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2011.02.012_bib11","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s002800100370","article-title":"Gemcitabine activity in cervical cancer cell lines","volume":"48","author":"Hernandez","year":"2001","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ijrobp.2011.02.012_bib12","first-page":"3218","article-title":"Metabolism of 2\u2032,2\u2032-difluoro-2\u2032-deoxycytidine and radiation sensitization of human colon carcinoma cells","volume":"54","author":"Shewach","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2011.02.012_bib13","first-page":"211","article-title":"Preclinical in vivo activity of 2\u20322\u2032-difluorodeoxycytidine against head and neck cancer","volume":"51","author":"Braakhuis","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2011.02.012_bib14","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/(SICI)1520-6823(1997)5:2<62::AID-ROI4>3.0.CO;2-H","article-title":"Enhancement of radiation-induced regrowth delay by gemcitabine in a human tumor xenograft model","volume":"5","author":"Joschko","year":"1997","journal-title":"Radiat Oncol Invest"},{"key":"10.1016\/j.ijrobp.2011.02.012_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2011.02.012_bib16","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1200\/JCO.2001.19.3.792","article-title":"Radiation concurrent with gemcitabine for locally advanced head and neck cancer: A phase I trial and intracellular drug incorporation study","volume":"19","author":"Eisbruch","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2011.02.012_bib17","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/00000421-200112000-00019","article-title":"Gemcitabine, cisplatin, and radiation in advanced unresectable squamous cell carcinoma of the head and neck","volume":"24","author":"Benasso","year":"2001","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2011.02.012_bib18","first-page":"R40","article-title":"Low dose gemcitabine with radiotherapy in advanced head and neck and thyroid cancer, a new radiosensitizing approach","volume":"126","author":"Wildfang","year":"2000","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ijrobp.2011.02.012_bib19","first-page":"30","article-title":"Gemcitabine once a week with radical radiation\u2014A phase I trial","volume":"2","author":"Huilgol","year":"2002","journal-title":"J Clin Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2011.02.012_bib20","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/annonc\/mdh071","article-title":"Phase II trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck","volume":"15","author":"Aguilar-Ponce","year":"2004","journal-title":"Ann Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301611002458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301611002458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T10:28:53Z","timestamp":1592562533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301611002458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0360301611002458"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2011.02.012","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}